New research provides evidence that the Alzheimer’s disease drug Lecanemab functions by activating a specific cleaning ...

Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in its Phase I/II clinical trial evaluating ...

TARA-002 demonstrates 72% complete response rate at any time in BCG-Naïve patientsTARA-002 demonstrates a 69% complete response rate at the ...

A new nanoparticle vaccine successfully prevented several aggressive cancers in mice, including pancreatic and melanoma. The ...

Mito-TEMPO（AbMole，M10919）的作用机制不仅限于简单的ROS清除，它还能调节多种线粒体相关信号通路和细胞生命活动。例如Mito-TEMPO在MCF-7细胞中，逆转了DHA诱导的ROS依赖性自噬激活，通过调节p-AMPKα/p-Ra ...

Study targets patients with advanced disease who have progressed on prior immunotherapy CatalYmtoday announced that the first patient has been dosed in the randomized Phase 2b GDFATHER-NSCLC-02 ...

Vestibular Migraine (VM) is a common clinical neurological disorder characterized by recurrent episodes of dizziness and headaches. It has a significant genetic predisposition and a high morbidity and ...

Over the past two decades, thoracic oncology has undergone a profound transformation, moving from limited chemotherapy ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

Blood Cancer United®—formerly The Leukemia & Lymphoma Society—will celebrate new data presented by Blood Cancer United funded ...

Spinal Cord Injury (SCI) is a devastating neurological disorder that often leads to permanent neural dysfunction. Current ...